Tuesday, June 05, 2012 3:47:28 PM
Atrinsic is Among the Companies in the Advertising Industry With the Lowest Enterprise Value to Sales Ratio (ATRN)
4 hours 21 minutes ago - F70
Financial News Network Online - News CornerBelow are the three companies in the Advertising industry with the lowest Enterprise Value (EV) to Sales ratios. EV/Sales gives investors an idea of how much it costs to buy the company's sales and the lower the ratio, the more undervalued the company is believed to be.Atrinsic (NASDAQ:ATRN) is lowest with EV/Sales of 0.07. Atrinsic Inc. offers digital and mobile entertainment products. The Company operates Internet entertainment portals, a gaming website, and a website offering storefront services to customers selling digital content. and Apollo Light Pipe. Orion Energy Systems offers energy savings and efficiency gains to commercial and industrial customers. Over the past year, Atrinsic has traded in a range of $0.01 to $6.15 and is now at $0.05, 410% above that low. Over the last five market days, the 200-day moving average (MA) has gone down 5.5% while the 50-day MA has declined 5.5%.
4 hours 21 minutes ago - F70
Financial News Network Online - News CornerBelow are the three companies in the Advertising industry with the lowest Enterprise Value (EV) to Sales ratios. EV/Sales gives investors an idea of how much it costs to buy the company's sales and the lower the ratio, the more undervalued the company is believed to be.Atrinsic (NASDAQ:ATRN) is lowest with EV/Sales of 0.07. Atrinsic Inc. offers digital and mobile entertainment products. The Company operates Internet entertainment portals, a gaming website, and a website offering storefront services to customers selling digital content. and Apollo Light Pipe. Orion Energy Systems offers energy savings and efficiency gains to commercial and industrial customers. Over the past year, Atrinsic has traded in a range of $0.01 to $6.15 and is now at $0.05, 410% above that low. Over the last five market days, the 200-day moving average (MA) has gone down 5.5% while the 50-day MA has declined 5.5%.
Recent PTIX News
- Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 • ACCESS Newswire • 03/17/2026 12:00:00 PM
- Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market • ACCESS Newswire • 03/10/2026 12:00:00 PM
- Results from Phase 1 Multiple-Dose Study of PT00114 • ACCESS Newswire • 12/09/2025 01:46:00 PM
- Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice • ACCESS Newswire • 11/27/2025 08:45:00 AM
- Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study • ACCESS Newswire • 11/13/2025 01:22:00 PM
- Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates • GlobeNewswire Inc. • 07/30/2025 12:30:00 PM
- Nasdaq Top 5 Premarket Losers • IH Market News • 05/20/2025 12:47:37 PM
- Protagenic Therapeutics Soars 190% on Merger to Launch Neuroactive Biopharma Firm • IH Market News • 05/19/2025 02:28:09 PM
- Nasdaq Top 5 Premarket Gainers • IH Market News • 05/19/2025 01:07:08 PM
